Proctitis causes rectal discomfort and bleeding. Learn what triggers it, how it's diagnosed, and which treatments actually ...

The Global Burden of Disease study highlights the rising cases of Inflammatory Bowel Disease in India, emphasizing the need ...

Spyre Therapeutics, Inc. ("Spyre" or the "Company") (NASDAQ:SYRE), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, dose optimization, and rational therapeutic ...

Fintel reports that on May 8, 2025, Chardan Capital downgraded their outlook for Seres Therapeutics (NasdaqGS:MCRB) from Buy ...

Cytoki Pharma ApS (Cytoki), a clinical-stage biotechnology company pioneering a new class of medicines that harness ...

A new study finds that women with rheumatoid arthritis, lupus, or other autoimmune conditions have twice the risk of dying ...

The European Commission (EC) has approved a Marketing Authorization (MA) for Tremfya (guselkumab) to treat adults with ...

Takeda forecast annual operating profit to rise 39% to Y475.00 billion. It expects savings from its enterprise-wide efficiency program, significant declines in restructuring expenses and lower ...

The Carolina Panthers will host their annual rookie minicamp on Friday and Saturday. Tetairoa McMillan, Nic Scourton, ...

Royalty Receipts was $788 million in the first quarter of 2025, an increase of 12% compared to $705 million in the first quarter of 2024. The increase was primarily driven by strong growth from the ...

Research and Development (R&D) expenses: R&D expenses were $22.9 million for the first quarter of 2025, compared to $33.7 million for the first quarter of 2024. General and Administrative (G&A) ...

Takeda’s Julie Kim argues that Trump’s idea to match drug prices to that of other countries could cost the industry up to $1 ...